Ammonia	O
-	O
lowering	O
activities	O
and	O
carbamoyl	B-GP
phosphate	I-GP
synthetase	I-GP
1	I-GP
(	O
Cps1	B-GP
)	O
induction	O
mechanism	O
of	O
a	O
natural	O
flavonoid	O

Objective	O

Ammonia	O
detoxification	O
is	O
essential	O
for	O
physiological	O
well	O
-	O
being	O
,	O
and	O
the	O
urea	O
cycle	O
in	O
liver	O
plays	O
a	O
predominant	O
role	O
in	O
ammonia	O
disposal	O
.	O

Nobiletin	O
(	O
NOB	O
),	O
a	O
natural	O
dietary	O
flavonoid	O
,	O
is	O
known	O
to	O
exhibit	O
various	O
physiological	O
efficacies	O
.	O

In	O
the	O
current	O
study	O
,	O
we	O
investigated	O
a	O
potential	O
role	O
of	O
NOB	O
in	O
ammonia	O
control	O
and	O
the	O
underlying	O
cellular	O
mechanism	O
.	O

Materials	O
/	O
methods	O

C57BL	B-OG
/	I-OG
6	I-OG
mice	I-OG
were	O
fed	O
with	O
regular	O
chow	O
(	O
RC	O
),	O
high	O
-	O
fat	O
(	O
HFD	O
)	O
or	O
high	O
-	O
protein	O
diet	O
(	O
HPD	O
)	O
and	O
treated	O
with	O
either	O
vehicle	O
or	O
NOB	O
.	O

Serum	O
and	O
/	O
or	O
urine	O
levels	O
of	O
ammonia	O
and	O
urea	O
were	O
measured	O
.	O

Liver	O
expression	O
of	O
genes	O
encoding	O
urea	O
cycle	O
enzymes	O
and	O
C	B-GP
/	I-GP
EBP	I-GP
transcription	B-GP
factors	I-GP
was	O
determined	O
over	O
the	O
circadian	O
cycle	O
.	O

Luciferase	B-GP
reporter	O
assays	O
were	O
carried	O
out	O
to	O
investigate	O
function	O
of	O
CCAAT	O
consensus	O
elements	O
on	O
the	O
carbamoyl	B-GP
phosphate	I-GP
synthetase	I-GP
(	O
Cps1	B-GP
)	O
gene	O
promoter	O
.	O

A	O
circadian	O
clock	B-GP
-	O
deficient	O
mouse	B-OG
mutant	O
,	O
ClockΔ19	O
/	O
Δ19	O
,	O
was	O
utilized	O
to	O
examine	O
a	O
requisite	O
role	O
of	O
the	O
circadian	O
clock	B-GP
in	O
mediating	O
NOB	O
induction	O
of	O
Cps1	B-GP
.	O

Results	O

NOB	O
was	O
able	O
to	O
lower	O
serum	O
ammonia	O
levels	O
in	O
mice	B-OG
fed	O
with	O
RC	O
,	O
HFD	O
or	O
HPD	O
.	O

Compared	O
with	O
RC	O
,	O
HFD	O
repressed	O
the	O
mRNA	O
and	O
protein	O
expression	O
of	O
Cps1	B-GP
,	O
encoding	O
the	O
rate	O
-	O
limiting	O
enzyme	O
of	O
the	O
urea	O
cycle	O
.	O

Interestingly	O
,	O
NOB	O
rescued	O
CPS1	B-GP
protein	O
levels	O
under	O
the	O
HFD	O
condition	O
via	O
induction	O
of	O
the	O
transcription	B-GP
factors	I-GP
C	B-GP
/	I-GP
EBPα	I-GP
and	O
C	B-GP
/	I-GP
EBPβ	I-GP
.	O

Expression	O
of	O
other	O
urea	O
cycle	O
genes	O
was	O
also	O
decreased	O
by	O
HFD	O
relative	O
to	O
RC	O
and	O
again	O
restored	O
by	O
NOB	O
to	O
varying	O
degrees	O
,	O
which	O
,	O
in	O
conjunction	O
with	O
Cps1	B-GP
promoter	O
reporter	O
analysis	O
,	O
suggested	O
a	O
C	B-GP
/	I-GP
EBP	I-GP
-	O
dependent	O
mechanism	O
for	O
the	O
co	O
-	O
induction	O
of	O
urea	O
cycle	O
genes	O
by	O
NOB	O
.	O

In	O
comparison	O
,	O
HPD	O
markedly	O
increased	O
CPS1	B-GP
levels	O
relative	O
to	O
RC	O
,	O
yet	O
NOB	O
did	O
not	O
further	O
enrich	O
CPS1	B-GP
to	O
a	O
significant	O
extent	O
.	O

Using	O
the	O
circadian	O
mouse	B-OG
mutant	O
ClockΔ19	O
/	O
Δ19	O
,	O
we	O
also	O
showed	O
that	O
a	O
functional	O
circadian	O
clock	B-GP
,	O
known	O
to	O
modulate	O
C	B-GP
/	I-GP
EBP	I-GP
and	O
CPS1	B-GP
expression	O
,	O
was	O
required	O
for	O
NOB	O
induction	O
of	O
CPS1	B-GP
under	O
the	O
HFD	O
condition	O
.	O

Conclusion	O

NOB	O
,	O
a	O
dietary	O
flavonoid	O
,	O
exhibits	O
a	O
broad	O
activity	O
in	O
ammonia	O
control	O
across	O
varying	O
diets	O
,	O
and	O
regulates	O
urea	O
cycle	O
function	O
via	O
C	B-GP
/	I-GP
EBP	I-GP
-	O
and	O
clock	B-GP
-	O
dependent	O
regulatory	O
mechanisms	O
.	O

Electronic	O
supplementary	O
material	O

The	O
online	O
version	O
of	O
this	O
article	O
(	O
doi	O
:	O
10	O
.	O
1186	O
/	O
s12986	O
-	O
015	O
-	O
0020	O
-	O
7	O
)	O
contains	O
supplementary	O
material	O
,	O
which	O
is	O
available	O
to	O
authorized	O
users	O
.	O

Introduction	O

Ammonia	O
detoxification	O
is	O
an	O
essential	O
bodily	O
function	O
required	O
for	O
nitrogen	O
homeostasis	O
and	O
physiological	O
well	O
-	O
being	O
[	O
1	O
–	O
3	O
].	O

Ammonia	O
molecules	O
are	O
produced	O
mainly	O
through	O
catabolism	O
of	O
amino	O
acid	O
and	O
other	O
nitrogenous	O
metabolites	O
in	O
tissues	O
,	O
and	O
also	O
via	O
amino	O
acid	O
deamination	O
and	O
urea	O
salvage	O
by	O
gut	O
bacteria	B-OG
[	O
1	O
,	O
4	O
].	O

Whereas	O
a	O
small	O
portion	O
of	O
ammonia	O
is	O
removed	O
via	O
direct	O
renal	O
excretion	O
,	O
the	O
urea	O
cycle	O
in	O
the	O
liver	O
plays	O
a	O
predominant	O
role	O
in	O
ammonia	O
disposal	O
,	O
converting	O
ammonia	O
to	O
the	O
relatively	O
harmless	O
urea	O
for	O
excretion	O
[	O
5	O
,	O
6	O
].	O

The	O
urea	O
cycle	O
consists	O
of	O
five	O
enzymatic	O
reactions	O
sequentially	O
taking	O
place	O
in	O
the	O
mitochondrial	O
matrix	O
and	O
the	O
cytoplasm	O
of	O
periportal	O
hepatocytes	O
[	O
7	O
,	O
8	O
].	O

Carbamoyl	B-GP
phosphate	I-GP
synthetase	I-GP
1	I-GP
(	O
CPS1	B-GP
)	O
catalyzes	O
the	O
first	O
reaction	O
wherein	O
ammonia	O
and	O
bicarbonate	O
combine	O
to	O
form	O
carbamoyl	O
phosphate	O
,	O
and	O
mice	B-OG
deficient	O
in	O
Cps1	B-GP
suffered	O
pronounced	O
hyperammonemia	B-DS
and	O
neonatal	O
lethality	O
[	O
9	O
].	O

As	O
a	O
strikingly	O
abundant	O
protein	O
comprising	O
as	O
much	O
as	O
20	O
%	O
of	O
total	O
mitochondrial	B-GP
matrix	I-GP
protein	I-GP
mass	O
[	O
10	O
],	O
CPS1	B-GP
is	O
also	O
subjected	O
to	O
diverse	O
molecular	O
and	O
cellular	O
regulation	O
.	O

Besides	O
the	O
classically	O
known	O
allosteric	O
activator	O
N	O
-	O
acetylglutamate	O
(	O
NAG	O
),	O
CPS1	B-GP
level	O
and	O
activity	O
are	O
also	O
regulated	O
by	O
complex	O
molecular	O
and	O
physiological	O
mechanisms	O
[	O
7	O
,	O
11	O
–	O
16	O
].	O

Furthermore	O
,	O
coordinate	O
induction	O
of	O
urea	O
cycle	O
components	O
has	O
also	O
been	O
reported	O
at	O
transcriptional	O
and	O
post	O
-	O
transcriptional	O
levels	O
[	O
7	O
,	O
17	O
].	O

An	O
emerging	O
cellular	O
mechanism	O
for	O
nitrogen	O
homeostasis	O
is	O
our	O
intrinsic	O
biological	O
timer	O
,	O
the	O
circadian	O
clock	B-GP
[	O
18	O
,	O
19	O
].	O

In	O
mammals	B-OG
,	O
core	O
clock	B-GP
genes	O
form	O
interlocked	O
feedback	O
loops	O
,	O
driving	O
gene	O
expression	O
to	O
regulate	O
various	O
metabolic	O
pathways	O
[	O
20	O
–	O
22	O
].	O

Several	O
earlier	O
studies	O
have	O
implicated	O
a	O
role	O
of	O
the	O
clock	B-GP
in	O
protein	O
or	O
nitrogen	O
metabolism	O
[	O
23	O
–	O
25	O
].	O

More	O
recently	O
,	O
it	O
was	O
shown	O
that	O
the	O
transcription	B-GP
factor	I-GP
Klf15	B-GP
is	O
encoded	O
by	O
a	O
clock	B-GP
-	O
controlled	O
gene	O
,	O
and	O
that	O
Klf15	B-GP
maintains	O
nitrogen	O
balance	O
via	O
regulation	O
of	O
the	O
second	O
urea	O
cycle	O
gene	O
Otc	B-GP
[	O
19	O
].	O

Furthermore	O
,	O
genomic	O
and	O
proteomic	O
studies	O
have	O
also	O
demonstrated	O
circadian	O
variation	O
of	O
Cps1	B-GP
mRNA	O
and	O
protein	O
expression	O
in	O
mouse	B-OG
liver	O
,	O
although	O
discrepancies	O
remain	O
concerning	O
mRNA	O
oscillation	O
and	O
protein	O
peaks	O
[	O
26	O
–	O
29	O
].	O

Apart	O
from	O
the	O
clock	B-GP
being	O
an	O
intrinsic	O
regulator	O
,	O
diet	O
is	O
an	O
external	O
factor	O
that	O
profoundly	O
influences	O
nitrogen	O
homeostasis	O
and	O
ammonia	O
metabolism	O
.	O

Dietary	O
management	O
for	O
genetic	O
hyperammonemia	B-DS
,	O
mainly	O
including	O
protein	O
restriction	O
and	O
supplementation	O
of	O
urea	O
cycle	O
substrate	O
,	O
serves	O
to	O
attenuate	O
ammonia	O
generation	O
and	O
/	O
or	O
bolster	O
ammonia	O
disposal	O
[	O
3	O
,	O
30	O
–	O
32	O
].	O

On	O
the	O
other	O
hand	O
,	O
dietary	O
challenges	O
also	O
strongly	O
influence	O
ammonia	O
metabolism	O
and	O
detoxification	O
.	O

For	O
example	O
,	O
the	O
ureagenic	O
capacity	O
of	O
the	O
urea	O
cycle	O
,	O
while	O
far	O
exceeding	O
demand	O
under	O
normal	O
conditions	O
[	O
14	O
],	O
has	O
been	O
shown	O
to	O
be	O
up	O
-	O
regulated	O
in	O
response	O
to	O
greater	O
metabolic	O
challenge	O
[	O
7	O
,	O
33	O
].	O

However	O
,	O
ammonia	O
control	O
under	O
varying	O
diet	O
conditions	O
is	O
not	O
well	O
characterized	O
,	O
and	O
little	O
is	O
known	O
regarding	O
functional	O
dietary	O
components	O
for	O
ammonia	O
control	O
besides	O
metabolic	O
substrates	O
[	O
30	O
,	O
34	O
].	O

Here	O
,	O
we	O
report	O
novel	O
ammonia	O
-	O
lowering	O
activities	O
and	O
clock	B-GP
-	O
dependent	O
mechanism	O
for	O
urea	O
cycle	O
regulation	O
of	O
a	O
natural	O
polyphenolic	O
flavonoid	O
,	O
Nobiletin	O
(	O
NOB	O
).	O

Materials	O
and	O
methods	O

Animals	B-OG

All	O
animal	B-OG
husbandry	O
and	O
experimental	O
procedures	O
were	O
carried	O
out	O
in	O
accordance	O
with	O
approved	O
IACUC	O
guidelines	O
and	O
animal	B-OG
protocols	O
by	O
the	O
University	O
of	O
Texas	O
Health	O
Science	O
Center	O
at	O
Houston	O
(	O
UTHealth	O
).	O

All	O
mice	B-OG
,	O
male	O
and	O
on	O
the	O
C57BL	O
/	O
6	O
background	O
,	O
were	O
group	O
-	O
housed	O
with	O
2	O
–	O
4	O
animals	B-OG
/	O
cage	O
under	O
12	O
:	O
12	O
light	O
/	O
dark	O
(	O
12	O
:	O
12	O
LD	O
)	O
cycles	O
or	O
constant	O
darkness	O
(	O
DD	O
)	O
when	O
indicated	O
.	O

The	O
point	O
of	O
light	O
-	O
on	O
is	O
considered	O
as	O
Zeitgeber	O
Time	O
(	O
ZT	O
)	O
0	O
,	O
whereas	O
the	O
onset	O
of	O
subjective	O
day	O
during	O
DD	O
is	O
considered	O
as	O
Circadian	O
Time	O
(	O
CT	O
)	O
0	O
.	O

Animals	B-OG
were	O
ad	O
libitum	O
fed	O
with	O
regular	O
chow	O
(	O
RC	O
;	O
LabDiet	O
5001	O
),	O
high	O
-	O
fat	O
diet	O
(	O
HFD	O
;	O
Research	O
Diets	O
D12492	O
)	O
or	O
high	O
-	O
protein	O
diet	O
(	O
HPD	O
;	O
Research	O
Diets	O
D04080301	O
).	O

Nobiletin	O
was	O
obtained	O
from	O
commercial	O
sources	O
including	O
Sigma	O
and	O
Selleck	O
,	O
and	O
administered	O
via	O
oral	O
gavage	O
(	O
200	O
mg	O
/	O
kg	O
in	O
0	O
.	O
5	O
%	O
Sodium	O
carboxymethyl	O
cellulose	O
)	O
every	O
other	O
day	O
.	O

Ammonia	O
and	O
urea	O
assays	O

Blood	O
and	O
urine	O
samples	O
were	O
collected	O
at	O
ZT6	O
and	O
ZT18	O
.	O

For	O
determination	O
of	O
serum	O
ammonia	O
and	O
urea	O
concentrations	O
,	O
we	O
employed	O
assay	O
kits	O
(	O
Sigma	O
,	O
AA0100	O
and	O
MAK006	O
,	O
respectively	O
)	O
according	O
to	O
the	O
manufacturer	O
’	O
s	O
protocols	O
.	O

Plasmids	O

The	O
proximal	O
Cps1	B-GP
enhancer	O
[	O
16	O
]	O
was	O
cloned	O
into	O
pGL3	O
Basic	O
(	O
Promega	O
)	O
using	O
C57BL6	B-OG
/	I-OG
J	I-OG
mouse	I-OG
genomic	O
DNA	O
as	O
PCR	O
template	O
with	O
pF	O
and	O
pR	O
primers	O
(	O
Additional	O
file	O
1	O
:	O
Table	O
S1	O
).	O

Site	O
-	O
directed	O
PCR	O
mutagenesis	O
was	O
performed	O
to	O
introduce	O
mutations	O
on	O
the	O
C	B-GP
/	I-GP
EBP	I-GP
binding	O
site	O
using	O
P	O
-	O
C	O
/	O
EBPmutF	O
and	O
P	O
-	O
C	O
/	O
EBPmutR	O
primers	O
(	O
Additional	O
file	O
1	O
:	O
Table	O
S1	O
).	O

Likewise	O
,	O
the	O
distal	O
enhancer	O
[	O
35	O
]	O
was	O
cloned	O
into	O
pGL3	O
Basic	O
using	O
dF	O
and	O
dR	O
primers	O
.	O

Three	O
C	B-GP
/	I-GP
EBP	I-GP
binding	O
sites	O
in	O
the	O
distal	O
enhancer	O
region	O
were	O
incorporated	O
by	O
DNA	O
synthesis	O
(	O
GeneScript	O
).	O

C	B-GP
/	I-GP
EBPα	I-GP
expression	O
vector	O
was	O
purchased	O
from	O
Addgene	O
(	O
ID12550	O
).	O

Luciferase	B-GP
reporter	O
assays	O

For	O
the	O
luminescence	O
assay	O
,	O
Hepa1	O
-	O
6	O
cells	O
(	O
ATCC	O
,	O
CRL	O
-	O
1830	O
)	O
were	O
plated	O
the	O
day	O
before	O
transfection	O
at	O
2	O
×	O
104	O
cells	O
per	O
well	O
in	O
96	O
-	O
well	O
plates	O
.	O

Cells	O
were	O
transfected	O
with	O
the	O
indicated	O
vectors	O
with	O
Renilla	B-OG
luciferase	B-GP
vector	O
for	O
internal	O
control	O
.	O

Twenty	O
four	O
hours	O
after	O
transfection	O
,	O
media	O
was	O
changed	O
to	O
recording	O
media	O
as	O
previously	O
described	O
[	O
36	O
]	O
and	O
treated	O
with	O
different	O
concentrations	O
of	O
Nobiletin	O
.	O

Sealed	O
cultures	O
were	O
placed	O
in	O
an	O
EnVision	O
microplate	O
reader	O
(	O
Perkin	O
Elmer	O
)	O
and	O
bioluminescence	O
from	O
the	O
tissue	O
was	O
recorded	O
.	O

Real	O
-	O
time	O
qPCR	O
and	O
Western	O
blot	O
analyses	O

Total	O
RNAs	O
purified	O
by	O
using	O
Trizol	O
were	O
used	O
for	O
cDNA	O
synthesis	O
and	O
real	O
-	O
time	O
qPCR	O
was	O
performed	O
with	O
an	O
Agilent	O
MaxPro3000	O
Thermocycler	O
using	O
SyBR	O
green	O
reaction	O
mix	O
(	O
GenDEPOT	O
).	O

The	O
qPCR	O
primers	O
used	O
are	O
listed	O
in	O
Additional	O
file	O
1	O
:	O
Table	O
S2	O
.	O

Tissue	O
collection	O
and	O
Western	O
blotting	O
was	O
performed	O
as	O
described	O
previously	O
[	O
37	O
,	O
38	O
].	O

Briefly	O
,	O
liver	O
tissue	O
samples	O
were	O
dissected	O
from	O
the	O
same	O
lobular	O
regions	O
in	O
different	O
animals	B-OG
to	O
ensure	O
experimental	O
consistency	O
.	O

The	O
samples	O
were	O
immediately	O
frozen	O
in	O
liquid	O
nitrogen	O
and	O
stored	O
at	O
−	O
80	O
°	O
C	O
prior	O
to	O
use	O
.	O

The	O
harvested	O
liver	O
tissues	O
were	O
homogenized	O
in	O
extraction	O
buffer	O
containing	O
0	O
.	O
1	O
%	O
TritonX	O
-	O
100	O
.	O

Protein	O
samples	O
were	O
separated	O
by	O
12	O
or	O
6	O
%	O
SDS	O
-	O
polyacrylamide	O
gel	O
then	O
transferred	O
to	O
a	O
nitrocellulose	O
membrane	O
.	O

Anti	O
-	O
CPS1	B-GP
(	O
Abcam	O
),	O
anti	O
-	O
C	B-GP
/	I-GP
EBPα	I-GP
(	O
Cell	O
Signaling	O
),	O
anti	O
-	O
C	B-GP
/	I-GP
EBPβ	I-GP
(	O
Abcam	O
)	O
antibodies	B-GP
were	O
used	O
.	O

Quantitation	O
of	O
Western	O
blot	O
results	O
was	O
carried	O
out	O
by	O
using	O
ImageJ	O
software	O
(	O
NIH	O
).	O

Immunohistochemistry	O

Liver	O
tissues	O
(	O
right	O
lateral	O
lobe	O
)	O
were	O
collected	O
at	O
the	O
indicated	O
times	O
and	O
immediately	O
fixed	O
in	O
10	O
%	O
buffered	O
formalin	O
.	O

For	O
immunohistochemistry	O
,	O
20	O
-	O
μm	O
sections	O
were	O
collected	O
using	O
a	O
VibroSlice	O
microtome	O
(	O
World	O
Precision	O
Instruments	O
)	O
and	O
processed	O
free	O
floating	O
.	O

Sections	O
were	O
incubated	O
with	O
rabbit	B-OG
anti	O
-	O
CPS1	B-GP
(	O
1	O
:	O
10	O
,	O
000	O
;	O
Abcam	O
),	O
followed	O
by	O
Alexa	O
Fluor	O
546	O
rabbit	B-OG
secondary	O
antibody	B-GP
(	O
1	O
:	O
1000	O
;	O
Invitrogen	O
).	O

After	O
30	O
min	O
of	O
DAPI	O
staining	O
(	O
5	O
μM	O
),	O
Vectashield	O
mounting	O
media	O
(	O
Vector	O
Labs	O
)	O
was	O
used	O
to	O
mount	O
the	O
liver	O
slices	O
.	O

Section	O
images	O
were	O
acquired	O
and	O
analyzed	O
by	O
using	O
a	O
Nikon	O
A1R	O
confocal	O
microscope	O
.	O

SDS	O
-	O
PAGE	O
and	O
mass	O
spectrometry	O

Liver	O
extracts	O
were	O
separated	O
on	O
SDS	O
-	O
PAGE	O
gels	O
and	O
minimally	O
stained	O
with	O
Coomassie	O
blue	O
.	O

The	O
MW	O
164KD	O
band	O
was	O
excised	O
and	O
digested	O
with	O
trypsin	B-GP
.	O

The	O
sample	O
was	O
subjected	O
to	O
mass	O
spectrometry	O
protein	O
ID	O
at	O
the	O
BCM	O
Proteome	O
Core	O
Facility	O
using	O
a	O
Velos	O
-	O
Orbitrap	O
mass	O
spectrometer	O
.	O

Spectral	O
data	O
were	O
then	O
identified	O
by	O
using	O
Proteome	O
Discoverer	O
Suites	O
with	O
Mascot	O
(	O
Orbitrap	O
data	O
)	O
software	O
[	O
39	O
].	O

Statistical	O
analysis	O

Unless	O
otherwise	O
stated	O
,	O
results	O
are	O
presented	O
as	O
mean	O
±	O
SEM	O
.	O

Data	O
were	O
analyzed	O
using	O
Student	O
’	O
s	O
t	O
-	O
test	O
,	O
one	O
-	O
way	O
ANOVA	O
followed	O
by	O
post	O
-	O
hoc	O
analysis	O
using	O
Dunnett	O
’	O
s	O
multiple	O
comparison	O
tests	O
or	O
two	O
-	O
way	O
ANOVA	O
followed	O
by	O
post	O
-	O
hoc	O
analysis	O
using	O
Bonferroni	O
test	O
as	O
appropriate	O
.	O

A	O
value	O
of	O
p	O
<	O
0	O
.	O
05	O
was	O
considered	O
statistically	O
significant	O
.	O

Results	O

NOB	O
improves	O
ammonium	O
detoxification	O

Among	O
a	O
growing	O
number	O
of	O
bioactive	O
polyphenols	O
,	O
Nobiletin	O
(	O
NOB	O
)	O
is	O
a	O
citrus	O
-	O
derived	O
dietary	O
flavonoid	O
with	O
diverse	O
physiological	O
functions	O
[	O
40	O
–	O
43	O
].	O

More	O
recently	O
,	O
NOB	O
has	O
been	O
shown	O
to	O
display	O
a	O
protective	O
role	O
against	O
high	O
-	O
fat	O
diet	O
(	O
HFD	O
)-	O
induced	O
obesity	B-DS
and	O
other	O
metabolic	O
dysfunctions	O
[	O
44	O
–	O
46	O
].	O

To	O
investigate	O
a	O
potential	O
role	O
of	O
NOB	O
in	O
nitrogen	O
homeostasis	O
,	O
we	O
examined	O
serum	O
ammonium	O
levels	O
in	O
wild	O
-	O
type	O
(	O
WT	O
)	O
mice	B-OG
under	O
different	O
diets	O
.	O

Under	O
RC	O
,	O
NOB	O
did	O
not	O
significantly	O
affect	O
body	O
weight	O
(	O
Fig	O
.	O
1a	O
).	O

Consistent	O
with	O
previous	O
findings	O
[	O
44	O
,	O
45	O
],	O
NOB	O
ameliorated	O
body	O
weight	O
gain	O
under	O
HFD	O
(	O
Fig	O
.	O
1a	O
).	O

Importantly	O
however	O
,	O
under	O
both	O
diets	O
,	O
NOB	O
markedly	O
reduced	O
serum	O
ammonium	O
levels	O
(	O
Fig	O
.	O
1b	O
).	O

At	O
Zeitgeber	O
Time	O
(	O
ZT	O
)	O
6	O
corresponding	O
to	O
mid	O
-	O
day	O
(	O
inactive	O
phase	O
),	O
NOB	O
led	O
to	O
a	O
more	O
pronounced	O
reduction	O
for	O
HFD	O
than	O
RC	O
(	O
27	O
.	O
5	O
%	O
vs	O
14	O
.	O
4	O
%)	O
(	O
Fig	O
.	O
1b	O
,	O
left	O
).	O

Ammonia	O
-	O
lowering	O
activities	O
of	O
NOB	O
were	O
also	O
observed	O
at	O
ZT18	O
corresponding	O
to	O
mid	O
-	O
night	O
when	O
mice	B-OG
were	O
active	O
(	O
Fig	O
.	O
1b	O
,	O
right	O
).	O

Whereas	O
attenuated	O
serum	O
ammonia	O
levels	O
were	O
observed	O
in	O
HFD	O
.	O
Veh	O
than	O
RC	O
.	O
Veh	O
,	O
likely	O
due	O
to	O
lower	O
protein	O
content	O
in	O
HFD	O
than	O
RC	O
(	O
20	O
%	O
vs	O
.	O
29	O
%	O
in	O
calories	O
),	O
NOB	O
treatment	O
diminished	O
the	O
ammonia	O
levels	O
in	O
both	O
diets	O
by	O
similar	O
degrees	O
.	O
Fig	O
.	O
1Nobiletin	O
(	O
NOB	O
)	O
lowers	O
serum	O
ammonia	O
levels	O
.	O
a	O
Body	O
weight	O
change	O
of	O
wild	O
-	O
type	O
(	O
WT	O
)	O
mice	B-OG
fed	O
with	O
regular	O
chow	O
(	O
RC	O
)	O
or	O
high	O
-	O
fat	O
diet	O
(	O
HFD	O
)	O
and	O
treated	O
with	O
either	O
vehicle	O
(	O
Veh	O
)	O
or	O
Nobiletin	O
(	O
NOB	O
)	O
for	O
10	O
weeks	O
(	O
n	O
=	O
11	O
–	O
12	O
).	O
***	O
p	O
<	O
0	O
.	O
001	O
.	O
b	O
Serum	O
ammonia	O
levels	O
at	O
Zeitgeber	O
Time	O
(	O
ZT	O
)	O
6	O
and	O
18	O
in	O
the	O
mice	B-OG
described	O
in	O
(	O
a	O
).	O

ZT0	O
corresponds	O
to	O
the	O
onset	O
of	O
light	O
phase	O
.	O
c	O
Body	O
weight	O
change	O
of	O
WT	O
mice	B-OG
fed	O
with	O
RC	O
or	O
high	O
-	O
protein	O
diet	O
(	O
HPD	O
)	O
and	O
treated	O
with	O
either	O
Veh	O
or	O
NOB	O
for	O
4	O
weeks	O
(	O
n	O
=	O
6	O
–	O
7	O
).	O
d	O
Serum	O
ammonia	O
levels	O
at	O
ZT6	O
and	O
ZT18	O
in	O
the	O
mice	B-OG
described	O
in	O
(	O
c	O
).	O

Data	O
are	O
presented	O
as	O
mean	O
±	O
SEM	O
.	O

For	O
panels	O
b	O
and	O
d	O
,	O
Student	O
’	O
s	O
t	O
-	O
test	O
:	O
Veh	O
vs	O
.	O
NOB	O
,	O
**	O
p	O
<	O
0	O
.	O
01	O
,	O
***	O
p	O
<	O
0	O
.	O
001	O
;	O
RC	O
vs	O
.	O
HFD	O
or	O
HPD	O
,	O
††	O
p	O
<	O
0	O
.	O
01	O

We	O
next	O
investigated	O
effects	O
of	O
NOB	O
under	O
high	O
-	O
protein	O
diet	O
(	O
HPD	O
),	O
corresponding	O
to	O
enhanced	O
protein	O
metabolism	O
and	O
ammonia	O
flux	O
[	O
19	O
].	O

NOB	O
did	O
not	O
significantly	O
affect	O
body	O
weight	O
in	O
these	O
mice	B-OG
(	O
Fig	O
.	O
1c	O
).	O

At	O
ZT6	O
,	O
serum	O
ammonia	O
levels	O
were	O
similar	O
between	O
RC	O
and	O
HPD	O
,	O
and	O
NOB	O
showed	O
a	O
modest	O
trend	O
of	O
reducing	O
serum	O
ammonia	O
levels	O
(	O
Fig	O
.	O
1d	O
,	O
left	O
).	O

Importantly	O
,	O
during	O
the	O
active	O
phase	O
at	O
ZT18	O
when	O
serum	O
ammonia	O
levels	O
were	O
significantly	O
elevated	O
in	O
HPD	O
,	O
NOB	O
robustly	O
reduced	O
serum	O
ammonia	O
to	O
RC	O
levels	O
(	O
Fig	O
.	O
1d	O
,	O
right	O
).	O

Together	O
,	O
these	O
results	O
indicated	O
a	O
broad	O
role	O
of	O
NOB	O
in	O
reducing	O
serum	O
ammonia	O
content	O
at	O
both	O
active	O
and	O
inactive	O
circadian	O
phases	O
under	O
RC	O
,	O
HFD	O
and	O
HPD	O
conditions	O
.	O

Furthermore	O
,	O
NOB	O
more	O
strongly	O
reduced	O
serum	O
ammonia	O
levels	O
under	O
HFD	O
and	O
HPD	O
at	O
ZT6	O
and	O
ZT18	O
respectively	O
,	O
serving	O
to	O
normalize	O
the	O
exaggerated	O
circadian	O
variation	O
between	O
active	O
and	O
inactive	O
phases	O
in	O
these	O
diets	O
compared	O
with	O
RC	O
.	O

Diet	O
-	O
specific	O
effects	O
of	O
NOB	O
on	O
CPS1	B-GP
expression	O

Carbamoyl	B-GP
phosphate	I-GP
synthetase	I-GP
I	I-GP
(	O
CPS1	B-GP
)	O
has	O
been	O
shown	O
to	O
accumulate	O
in	O
a	O
circadian	O
manner	O
;	O
however	O
,	O
CPS1	B-GP
proteins	O
are	O
exceedingly	O
abundant	O
and	O
discrepancy	O
in	O
circadian	O
pattern	O
exists	O
[	O
26	O
,	O
27	O
].	O

We	O
therefore	O
conducted	O
Western	O
blotting	O
to	O
examine	O
CPS1	B-GP
protein	O
levels	O
in	O
mouse	B-OG
liver	O
over	O
circadian	O
time	O
course	O
.	O

While	O
largely	O
unchanged	O
between	O
Veh	O
and	O
NOB	O
treatment	O
under	O
RC	O
conditions	O
based	O
on	O
2	O
-	O
way	O
ANOVA	O
,	O
CPS1	B-GP
levels	O
were	O
significantly	O
reduced	O
in	O
HFD	O
.	O
Veh	O
compared	O
with	O
RC	O
(	O
Fig	O
.	O
2a	O
and	O
Additional	O
file	O
1	O
:	O
Figure	O
S1A	O
)	O
[	O
47	O
].	O

Strikingly	O
,	O
NOB	O
restored	O
CPS1	B-GP
in	O
HFD	O
to	O
RC	O
levels	O
(	O
Fig	O
.	O
2a	O
).	O

We	O
also	O
confirmed	O
the	O
above	O
results	O
using	O
Coomassie	O
staining	O
followed	O
by	O
mass	O
spectrometry	O
(	O
Additional	O
file	O
1	O
:	O
Figure	O
S1B	O
and	O
Table	O
S3	O
).	O

Furthermore	O
,	O
confocal	O
microscopy	O
using	O
anti	O
-	O
CPS1	B-GP
antibody	B-GP
also	O
clearly	O
showed	O
recovered	O
CPS1	B-GP
in	O
livers	O
from	O
HFD	O
.	O
NOB	O
mice	B-OG
relative	O
to	O
HFD	O
.	O
Veh	O
(	O
Fig	O
.	O
2b	O
and	O
Additional	O
file	O
1	O
:	O
Figure	O
S1C	O
).	O

Real	O
-	O
time	O
qPCR	O
analysis	O
further	O
revealed	O
strong	O
repression	O
of	O
Cps1	B-GP
messenger	O
levels	O
by	O
HFD	O
relative	O
to	O
RC	O
(	O
Fig	O
.	O
2c	O
),	O
consistent	O
with	O
its	O
effect	O
on	O
CPS1	B-GP
proteins	O
.	O

Importantly	O
,	O
NOB	O
restored	O
Cps1	B-GP
mRNA	O
expression	O
,	O
mirroring	O
the	O
changes	O
in	O
CPS1	B-GP
protein	O
.	O
Fig	O
.	O
2NOB	O
modulates	O
Cps1	B-GP
mRNA	O
and	O
protein	O
expression	O
.	O
a	O
Total	O
protein	O
extracts	O
were	O
prepared	O
from	O
liver	O
samples	O
collected	O
from	O
the	O
four	O
diet	O
/	O
treatment	O
groups	O
of	O
wild	O
-	O
type	O
mice	B-OG
at	O
the	O
indicated	O
circadian	O
time	O
points	O
(	O
n	O
=	O
3	O
).	O

Western	O
blotting	O
analysis	O
was	O
performed	O
using	O
anti	O
-	O
CPS1	B-GP
antibody	B-GP
.	O
RC	O
regular	O
chow	O
,	O
HFD	O
high	O
-	O
fat	O
diet	O
,	O
Veh	O
vehicle	O
,	O
NOB	O
Nobiletin	O
.	O

The	O
results	O
shown	O
are	O
representative	O
of	O
three	O
independent	O
experiments	O
.	O

See	O
Additional	O
file	O
1	O
:	O
Figure	O
S1A	O
for	O
quantitative	O
analysis	O
.	O
b	O
Immunohistochemical	O
staining	O
of	O
CPS1	B-GP
in	O
liver	O
sections	O
from	O
mice	B-OG
with	O
the	O
indicated	O
diet	O
and	O
treatment	O
at	O
ZT2	O
.	O
c	O
Real	O
-	O
time	O
RT	O
-	O
PCR	O
analysis	O
of	O
Cps1	B-GP
in	O
liver	O
samples	O
collected	O
as	O
in	O
(	O
a	O
).	O

Data	O
are	O
presented	O
as	O
mean	O
±	O
SEM	O
(	O
n	O
=	O
3	O
).	O

Two	O
-	O
way	O
ANOVA	O
with	O
Bonferroni	O
post	O
-	O
hoc	O
tests	O
shows	O
significant	O
statistical	O
differences	O
between	O
HFD	O
.	O
Veh	O
and	O
other	O
three	O
groups	O
(	O
p	O
<	O
0	O
.	O
0001	O
).	O
d	O
Western	O
blotting	O
analysis	O
of	O
protein	O
lysates	O
of	O
liver	O
samples	O
collected	O
at	O
ZT	O
6	O
and	O
18	O
from	O
mice	B-OG
with	O
the	O
indicated	O
diet	O
and	O
treatment	O
(	O
n	O
=	O
3	O
).	O

HPD	O
indicates	O
high	O
-	O
protein	O
diet	O
.	O

The	O
images	O
shown	O
to	O
the	O
left	O
are	O
representative	O
of	O
three	O
independent	O
experiments	O
.	O

Quantitation	O
of	O
Western	O
blots	O
was	O
carried	O
out	O
and	O
the	O
results	O
,	O
presented	O
as	O
mean	O
±	O
SEM	O
,	O
are	O
shown	O
in	O
the	O
lower	O
panel	O
.	O

Two	O
-	O
way	O
ANOVA	O
with	O
Bonferroni	O
post	O
-	O
hoc	O
tests	O
,	O
RC	O
vs	O
.	O
HPD	O
,	O
***	O
p	O
<	O
0	O
.	O
001	O
.	O
e	O
Real	O
-	O
time	O
qPCR	O
analysis	O
was	O
carried	O
out	O
using	O
total	O
RNAs	O
extracted	O
from	O
the	O
liver	O
samples	O
described	O
in	O
(	O
d	O
).	O

The	O
results	O
are	O
presented	O
as	O
mean	O
±	O
SEM	O
.	O

Two	O
-	O
way	O
ANOVA	O
with	O
Bonferroni	O
post	O
-	O
hoc	O
tests	O
,	O
RC	O
vs	O
.	O
HPD	O
,	O
*	O
p	O
<	O
0	O
.	O
05	O

We	O
also	O
examined	O
effects	O
of	O
HPD	O
on	O
CPS1	B-GP
levels	O
.	O

HPD	O
enhanced	O
the	O
abundance	O
of	O
CPS1	B-GP
by	O
approximately	O
20	O
%	O
(	O
Fig	O
.	O
2d	O
),	O
suggesting	O
a	O
role	O
of	O
CPS1	B-GP
induction	O
to	O
cope	O
with	O
increased	O
dietary	O
protein	O
intake	O
.	O

HPD	O
feeding	O
exerted	O
similar	O
modest	O
inducing	O
effects	O
on	O
Cps1	B-GP
mRNA	O
compared	O
with	O
RC	O
(	O
Fig	O
.	O
2e	O
).	O

NOB	O
treatment	O
,	O
on	O
the	O
other	O
hand	O
,	O
did	O
not	O
further	O
increase	O
CPS1	B-GP
protein	O
level	O
under	O
HPD	O
(	O
Fig	O
.	O
2d	O
),	O
yet	O
seemed	O
to	O
alter	O
the	O
mRNA	O
expression	O
with	O
a	O
slight	O
increase	O
at	O
ZT18	O
(	O
Fig	O
.	O
2e	O
).	O

These	O
results	O
indicated	O
opposing	O
effects	O
of	O
HFD	O
and	O
HPD	O
on	O
Cps1	B-GP
expression	O
,	O
suggesting	O
that	O
ammonia	O
-	O
lowering	O
activities	O
of	O
NOB	O
entail	O
diet	O
-	O
specific	O
CPS1	B-GP
regulatory	O
mechanisms	O
.	O

NOB	O
restored	O
levels	O
of	O
C	B-GP
/	I-GP
EBP	I-GP
transcription	B-GP
factors	I-GP
repressed	O
under	O
HFD	O

We	O
next	O
focused	O
on	O
HFD	O
where	O
the	O
above	O
results	O
indicated	O
NOB	O
-	O
mediated	O
transcriptional	O
induction	O
of	O
Cps1	B-GP
.	O

The	O
transcription	B-GP
factors	I-GP
C	B-GP
/	I-GP
EBPα	I-GP
and	O
C	B-GP
/	I-GP
EBPβ	I-GP
are	O
known	O
to	O
play	O
important	O
roles	O
in	O
energy	O
homeostasis	O
and	O
urea	O
cycle	O
expression	O
[	O
7	O
,	O
48	O
,	O
49	O
].	O

Consistent	O
with	O
previous	O
results	O
[	O
50	O
],	O
liver	O
expression	O
of	O
both	O
Cebp	B-GP
genes	O
exhibited	O
clear	O
circadian	O
oscillation	O
in	O
RC	O
;	O
somewhat	O
surprisingly	O
,	O
NOB	O
moderately	O
elevated	O
Cebpa	B-GP
expression	O
,	O
yet	O
strongly	O
repressed	O
Cebpb	B-GP
(	O
Fig	O
.	O
3a	O
).	O

HFD	O
significantly	O
dampened	O
levels	O
and	O
circadian	O
amplitude	O
(	O
peak	O
/	O
trough	O
difference	O
)	O
of	O
both	O
Cebp	B-GP
mRNA	O
expression	O
,	O
and	O
interestingly	O
also	O
reversed	O
their	O
circadian	O
phase	O
.	O

NOB	O
treatment	O
largely	O
restored	O
Cebpa	B-GP
mRNA	O
expression	O
(	O
ZT14	O
)	O
and	O
circadian	O
phase	O
relative	O
to	O
RC	O
(	O
Fig	O
.	O
3a	O
).	O
Fig	O
.	O
3NOB	O
rescued	O
Cebpa	B-GP
and	O
Cebpb	B-GP
mRNA	O
and	O
protein	O
circadian	O
expression	O
in	O
the	O
liver	O
from	O
HFD	O
fed	O
mice	B-OG
.	O
a	O
Real	O
-	O
time	O
RT	O
-	O
PCR	O
analysis	O
of	O
Cebpa	B-GP
and	O
Cebpb	B-GP
in	O
livers	O
collected	O
at	O
the	O
indicated	O
circadian	O
times	O
from	O
mice	B-OG
with	O
the	O
indicated	O
diet	O
and	O
treatment	O
as	O
in	O
Fig	O
.	O
2a	O
.	O

Student	O
’	O
s	O
t	O
-	O
test	O
:	O
RC	O
.	O
Veh	O
vs	O
.	O
HFD	O
.	O
Veh	O
,	O
*	O
p	O
<	O
0	O
.	O
05	O
;	O
HFD	O
.	O
Veh	O
vs	O
.	O
HFD	O
.	O
NOB	O
,	O
†	O
p	O
<	O
0	O
.	O
05	O
.	O
b	O
Western	O
blotting	O
was	O
performed	O
using	O
total	O
liver	O
protein	O
lysates	O
with	O
the	O
indicated	O
antibodies	B-GP
.	O

The	O
results	O
are	O
representative	O
of	O
three	O
independent	O
experiments	O
.	O

See	O
Additional	O
file	O
1	O
:	O
Figure	O
S2	O
for	O
quantitative	O
analysis	O

HFD	O
also	O
significantly	O
down	O
-	O
regulated	O
protein	O
levels	O
of	O
C	B-GP
/	I-GP
EBPα	I-GP
p42	B-GP
,	O
the	O
active	O
form	O
[	O
51	O
],	O
across	O
the	O
circadian	O
cycle	O
(	O
HFD	O
.	O
Veh	O
vs	O
.	O
RC	O
.	O
Veh	O
;	O
Fig	O
.	O
3b	O
and	O
Additional	O
file	O
1	O
:	O
Figure	O
S2A	O
).	O

In	O
comparison	O
,	O
the	O
amount	O
of	O
p30	B-GP
,	O
the	O
truncated	O
form	O
lacking	O
the	O
N	O
-	O
terminal	O
transactivation	O
domain	O
,	O
was	O
also	O
reduced	O
,	O
albeit	O
to	O
a	O
lesser	O
degree	O
(	O
Fig	O
.	O
3b	O
and	O
Additional	O
file	O
1	O
:	O
Figure	O
S2B	O
).	O

Compared	O
with	O
Veh	O
,	O
NOB	O
did	O
not	O
show	O
significant	O
effects	O
on	O
p42	B-GP
/	O
p30	B-GP
levels	O
in	O
RC	O
,	O
yet	O
appeared	O
to	O
reverse	O
their	O
reduction	O
by	O
HFD	O
to	O
RC	O
levels	O
(	O
Fig	O
.	O
3b	O
and	O
Additional	O
file	O
1	O
:	O
Figure	O
S2A	O
).	O

HFD	O
was	O
previously	O
reported	O
to	O
increase	O
C	B-GP
/	I-GP
EBPβ	I-GP
(	O
LAP	B-GP
and	O
LIP	B-GP
)	O
levels	O
in	O
mouse	B-OG
liver	O
[	O
52	O
].	O

In	O
comparison	O
,	O
our	O
circadian	O
analysis	O
revealed	O
a	O
C	B-GP
/	I-GP
EBPβ	I-GP
(	O
LAP	B-GP
)	O
phase	O
shift	O
in	O
HFD	O
(	O
Fig	O
.	O
3b	O
and	O
Additional	O
file	O
1	O
:	O
Figure	O
S2C	O
).	O

Whereas	O
both	O
RC	O
.	O
Veh	O
and	O
RC	O
.	O
NOB	O
showed	O
peak	O
C	B-GP
/	I-GP
EBPβ	I-GP
expression	O
at	O
ZT20	O
,	O
HFD	O
shifted	O
the	O
peak	O
to	O
ZT14	O
,	O
with	O
HFD	O
.	O
NOB	O
displaying	O
a	O
slight	O
increase	O
over	O
HFD	O
.	O
Veh	O
(	O
Fig	O
.	O
3b	O
and	O
Additional	O
file	O
1	O
:	O
Figure	O
S2C	O
).	O

These	O
results	O
illustrated	O
circadian	O
-	O
and	O
diet	O
-	O
dependent	O
expression	O
patterns	O
of	O
C	B-GP
/	I-GP
EBPs	I-GP
and	O
a	O
novel	O
function	O
of	O
NOB	O
in	O
restoring	O
C	B-GP
/	I-GP
EBP	I-GP
levels	O
repressed	O
by	O
HFD	O
.	O

C	B-GP
/	I-GP
EBP	I-GP
site	O
mutations	O
on	O
the	O
Cps1	B-GP
promoter	O
abolished	O
NOB	O
effects	O

Previous	O
studies	O
have	O
identified	O
both	O
proximal	O
and	O
distal	O
C	B-GP
/	I-GP
EBP	I-GP
sites	O
in	O
the	O
Cps1	B-GP
promoter	O
[	O
16	O
,	O
35	O
,	O
53	O
].	O

We	O
next	O
generated	O
reporter	O
constructs	O
containing	O
either	O
the	O
intact	O
Cps1	B-GP
promoter	O
or	O
mutant	O
promoters	O
respectively	O
deficient	O
in	O
either	O
C	B-GP
/	I-GP
EBP	I-GP
sites	O
(	O
Fig	O
.	O
4a	O
).	O

NOB	O
was	O
found	O
to	O
dose	O
-	O
dependently	O
activate	O
reporter	O
expression	O
from	O
the	O
WT	O
construct	O
with	O
an	O
intact	O
promoter	O
(	O
Fig	O
.	O
4b	O
and	O
c	O
).	O

Distal	O
mutations	O
markedly	O
repressed	O
the	O
reporter	O
expression	O
,	O
yet	O
seemed	O
to	O
at	O
least	O
partially	O
retain	O
NOB	O
response	O
as	O
NOB	O
increased	O
mutant	O
reporter	O
expression	O
relative	O
to	O
DMSO	O
(	O
Fig	O
.	O
4b	O
).	O

In	O
comparison	O
,	O
while	O
not	O
significantly	O
affecting	O
the	O
baseline	O
expression	O
level	O
,	O
proximal	O
mutations	O
abolished	O
NOB	O
dose	O
-	O
dependent	O
induction	O
seen	O
in	O
the	O
WT	O
construct	O
(	O
Fig	O
.	O
4c	O
).	O

C	B-GP
/	I-GP
EBPα	I-GP
co	O
-	O
transfection	O
activated	O
both	O
proximal	O
and	O
distal	O
WT	O
reporter	O
expression	O
,	O
but	O
showed	O
no	O
effects	O
on	O
mutant	O
constructs	O
in	O
the	O
absence	O
of	O
NOB	O
.	O

These	O
results	O
suggested	O
that	O
the	O
proximal	O
C	B-GP
/	I-GP
EBP	I-GP
consensus	O
site	O
plays	O
a	O
major	O
role	O
in	O
mediating	O
the	O
NOB	O
induction	O
of	O
Cps1	B-GP
.	O
Fig	O
.	O
4C	O
/	O
EBP	O
binding	O
site	O
mutations	O
in	O
proximal	O
and	O
distal	O
Cps1	B-GP
enhancer	O
regions	O
impaired	O
NOB	O
-	O
mediated	O
reporter	O
activation	O
.	O
a	O
Diagram	O
of	O
distal	O
and	O
proximal	O
C	B-GP
/	I-GP
EBP	I-GP
sites	O
on	O
the	O
Cps1	B-GP
promoter	O
region	O
.	O
b	O
and	O
c	O
Hepa1	O
-	O
6	O
cells	O
were	O
transfected	O
with	O
reporter	O
constructs	O
containing	O
wild	O
-	O
type	O
(	O
WT	O
;	O
white	O
bars	O
)	O
and	O
C	B-GP
/	I-GP
EBP	I-GP
binding	O
site	O
mutated	O
(	O
black	O
bars	O
)	O
enhancer	O
regions	O
,	O
and	O
treated	O
with	O
NOB	O
at	O
the	O
indicated	O
doses	O
.	O

Co	O
-	O
transfection	O
of	O
C	B-GP
/	I-GP
EBPα	I-GP
expression	O
construct	O
was	O
also	O
carried	O
out	O
in	O
parallel	O
.	O

Each	O
value	O
represented	O
mean	O
±	O
SEM	O
of	O
three	O
replicates	O
from	O
a	O
single	O
assay	O
.	O

The	O
results	O
are	O
representative	O
of	O
at	O
least	O
three	O
independent	O
experiments	O
.	O
b	O
and	O
c	O
show	O
results	O
from	O
reporter	O
constructs	O
containing	O
distal	O
and	O
proximal	O
WT	O
and	O
mutant	O
enhancers	O
respectively	O
.	O

Two	O
-	O
way	O
ANOVA	O
with	O
Bonferroni	O
post	O
-	O
hoc	O
tests	O
:	O
significant	O
main	O
effects	O
of	O
plasmid	O
construct	O
,	O
(	O
b	O
)	O
F	O
=	O
81	O
.	O
43	O
,	O
p	O
<	O
0	O
.	O
001	O
,	O
(	O
c	O
)	O
F	O
=	O
254	O
.	O
97	O
,	O
p	O
<	O
0	O
.	O
0001	O
;	O
NOB	O
concentration	O
effect	O
,	O
(	O
b	O
)	O
F	O
=	O
47	O
.	O
39	O
,	O
p	O
<	O
0	O
.	O
0001	O
,	O
(	O
c	O
)	O
F	O
=	O
42	O
.	O
01	O
,	O
p	O
<	O
0	O
.	O
0001	O
;	O
and	O
a	O
significant	O
interaction	O
between	O
constructs	O
and	O
NOB	O
concentration	O
,	O
(	O
b	O
)	O
F	O
=	O
23	O
,	O
p	O
<	O
0	O
.	O
0001	O
,	O
(	O
c	O
)	O
F	O
=	O
24	O
.	O
37	O
,	O
p	O
<	O
0	O
.	O
0001	O

Transcriptional	O
regulation	O
of	O
other	O
urea	O
cycle	O
genes	O
by	O
NOB	O
under	O
HFD	O

A	O
number	O
of	O
pioneering	O
studies	O
have	O
provided	O
strong	O
evidence	O
for	O
co	O
-	O
regulation	O
of	O
urea	O
cycle	O
genes	O
by	O
diets	O
,	O
hormones	O
,	O
cAMP	O
and	O
other	O
factors	O
,	O
likely	O
as	O
an	O
evolutionary	O
strategy	O
to	O
efficiently	O
perform	O
ureagenesis	O
in	O
response	O
to	O
various	O
internal	O
and	O
external	O
cues	O
[	O
8	O
,	O
20	O
,	O
35	O
,	O
54	O
–	O
56	O
].	O

In	O
particular	O
,	O
C	B-GP
/	I-GP
EBP	I-GP
sites	O
are	O
found	O
on	O
several	O
urea	O
cycle	O
genes	O
(	O
Fig	O
.	O
5a	O
)	O
[	O
7	O
,	O
8	O
].	O

Under	O
RC	O
,	O
NOB	O
treatment	O
showed	O
only	O
modest	O
effects	O
on	O
expression	O
of	O
the	O
four	O
other	O
urea	O
cycle	O
genes	O
(	O
Otc	B-GP
,	O
Ass1	B-GP
,	O
Asl	B-GP
,	O
Arg1	B-GP
)	O
relative	O
to	O
Veh	O
controls	O
(	O
Fig	O
.	O
5b	O
-	O
e	O
).	O

Strikingly	O
,	O
whereas	O
HFD	O
generally	O
repressed	O
their	O
mRNA	O
levels	O
and	O
also	O
elicited	O
strong	O
phase	O
shifts	O
(	O
Fig	O
.	O
5	O
),	O
NOB	O
enhanced	O
their	O
expression	O
and	O
/	O
or	O
amplitude	O
,	O
and	O
interestingly	O
also	O
correct	O
circadian	O
phases	O
.	O

Note	O
that	O
a	O
putative	O
C	B-GP
/	I-GP
EBP	I-GP
site	O
on	O
the	O
Ass1	B-GP
promoter	O
has	O
not	O
been	O
reported	O
,	O
suggesting	O
a	O
secondary	O
effect	O
by	O
C	B-GP
/	I-GP
EBP	I-GP
or	O
other	O
transcriptional	O
mechanisms	O
[	O
35	O
].	O

Since	O
C	B-GP
/	I-GP
EBPs	I-GP
are	O
master	O
regulators	O
of	O
overall	O
hepatic	O
metabolic	O
circuits	O
including	O
glucose	O
and	O
lipid	O
metabolism	O
,	O
coordinate	O
regulation	O
of	O
urea	O
cycle	O
genes	O
by	O
C	B-GP
/	I-GP
EBPs	I-GP
may	O
enable	O
metabolic	O
cross	O
-	O
talk	O
between	O
nitrogen	O
homeostasis	O
and	O
energy	O
metabolism	O
[	O
55	O
,	O
57	O
].	O
Fig	O
.	O
5NOB	O
coordinately	O
enhanced	O
urea	O
cycle	O
gene	O
expression	O
.	O
a	O
Diagram	O
of	O
C	B-GP
/	I-GP
EBP	I-GP
sites	O
on	O
the	O
genomic	O
regions	O
for	O
urea	O
cycle	O
genes	O
including	O
Otc	B-GP
,	O
Ass1	B-GP
,	O
Asl	B-GP
,	O
and	O
Arg1	B-GP
.	O
b	O
-	O
e	O
Liver	O
samples	O
were	O
collected	O
from	O
the	O
four	O
diet	O
/	O
treatment	O
groups	O
of	O
wild	O
-	O
type	O
mice	B-OG
at	O
the	O
indicated	O
circadian	O
time	O
points	O
.	O

Total	O
RNAs	O
were	O
purified	O
for	O
real	O
-	O
time	O
RT	O
-	O
PCR	O
analysis	O
using	O
primers	O
for	O
the	O
four	O
urea	O
cycle	O
genes	O
,	O
including	O
Otc	B-GP
(	O
b	O
),	O
Ass1c	B-GP
,	O
Asl	B-GP
d	O
and	O
Arg1	B-GP
e	O
.	O
RC	O
regular	O
chow	O
,	O
HFD	O
high	O
-	O
fat	O
diet	O
,	O
Veh	O
vehicle	O
,	O
NOB	O
Nobiletin	O
.	O

Data	O
are	O
presented	O
as	O
mean	O
±	O
SEM	O
(	O
n	O
=	O
3	O
).	O

Two	O
-	O
way	O
ANOVA	O
with	O
Bonferroni	O
post	O
-	O
hoc	O
tests	O
,	O
RC	O
.	O
Veh	O
vs	O
.	O
HFD	O
.	O
Veh	O
,	O
a	O
p	O
<	O
0	O
.	O
0001	O
,	O
b	O
p	O
<	O
0	O
.	O
01	O
,	O
c	O
p	O
<	O
0	O
.	O
05	O
,	O
d	O
p	O
<	O
0	O
.	O
01	O
.	O

Student	O
’	O
s	O
t	O
-	O
test	O
,	O
HFD	O
.	O
Veh	O
vs	O
.	O
HFD	O
.	O
NOB	O
,	O
*	O
p	O
<	O
0	O
.	O
05	O
,	O
**	O
p	O
<	O
0	O
.	O
01	O

Circadian	O
ClockΔ19	O
/	O
Δ19	O
mutant	O
mice	B-OG
displayed	O
attenuated	O
CPS1	B-GP
and	O
C	B-GP
/	I-GP
EBP	I-GP
levels	O

Consistent	O
with	O
previous	O
studies	O
[	O
27	O
,	O
50	O
,	O
58	O
],	O
our	O
data	O
thus	O
far	O
indicated	O
that	O
both	O
Cps1	B-GP
and	O
Cebp	B-GP
genes	O
are	O
subjected	O
to	O
circadian	O
control	O
and	O
display	O
rhythmic	O
patterns	O
of	O
expression	O
.	O

To	O
directly	O
examine	O
whether	O
the	O
circadian	O
clock	B-GP
plays	O
an	O
essential	O
role	O
in	O
Cps1	B-GP
regulation	O
,	O
we	O
employed	O
ClockΔ19	O
/	O
Δ19	O
mutant	O
mice	B-OG
(	O
Clk	O
)	O
which	O
express	O
a	O
dominant	O
negative	O
version	O
of	O
CLOCK	B-GP
proteins	O
and	O
thus	O
are	O
severely	O
impaired	O
in	O
circadian	O
rhythms	O
[	O
59	O
,	O
60	O
].	O

Compared	O
with	O
WT	O
,	O
CPS1	B-GP
,	O
C	B-GP
/	I-GP
EBPα	I-GP
p30	B-GP
and	O
C	B-GP
/	I-GP
EBPβ	I-GP
protein	O
levels	O
were	O
markedly	O
reduced	O
and	O
became	O
largely	O
arrhythmic	O
in	O
Clk	O
under	O
RC	O
feeding	O
and	O
constant	O
darkness	O
(	O
DD	O
)	O
conditions	O
(	O
Fig	O
.	O
6a	O
and	O
see	O
also	O
quantification	O
in	O
Additional	O
file	O
1	O
:	O
Figure	O
S3	O
).	O

In	O
comparison	O
,	O
p42	B-GP
expression	O
and	O
oscillation	O
were	O
maintained	O
in	O
Clk	O
mice	B-OG
,	O
yet	O
interestingly	O
displayed	O
a	O
reversed	O
circadian	O
phase	O
pattern	O
(	O
Fig	O
.	O
6a	O
and	O
Additional	O
file	O
1	O
:	O
Figure	O
S3B	O
).	O

These	O
observations	O
illustrated	O
gene	O
-	O
or	O
isoform	O
-	O
specific	O
circadian	O
expression	O
regulation	O
.	O

Furthermore	O
,	O
pronounced	O
expression	O
changes	O
in	O
C	B-GP
/	I-GP
EBP	I-GP
subunits	O
were	O
observed	O
in	O
the	O
mutant	O
mice	B-OG
,	O
including	O
both	O
phase	O
shifts	O
and	O
reduced	O
levels	O
(	O
p30	B-GP
and	O
C	B-GP
/	I-GP
EBPβ	I-GP
).	O
Cps1	B-GP
and	O
Cebpa	B-GP
mRNA	O
expression	O
was	O
also	O
compromised	O
in	O
the	O
mutant	O
mice	B-OG
,	O
showing	O
strongly	O
reduced	O
levels	O
and	O
dampened	O
circadian	O
amplitude	O
(	O
Fig	O
.	O
6b	O
).	O

In	O
comparison	O
,	O
Cebpb	B-GP
mRNA	O
expression	O
exhibited	O
a	O
marked	O
phase	O
shift	O
in	O
the	O
mutant	O
compared	O
with	O
WT	O
(	O
Fig	O
.	O
6b	O
,	O
bottom	O
),	O
while	O
maintaining	O
a	O
normal	O
amplitude	O
.	O

Whereas	O
CPS1	B-GP
levels	O
were	O
lower	O
in	O
Clk	O
than	O
WT	O
,	O
neither	O
HFD	O
nor	O
NOB	O
in	O
mutant	O
mice	B-OG
conferred	O
significant	O
changes	O
(	O
Fig	O
.	O
6c	O
;	O
lower	O
panel	O
:	O
quantification	O
).	O

These	O
results	O
together	O
indicated	O
a	O
critical	O
role	O
of	O
a	O
functional	O
clock	B-GP
to	O
mediate	O
NOB	O
induction	O
of	O
CPS1	B-GP
.	O
Fig	O
.	O
6NOB	O
restored	O
Cps1	B-GP
and	O
Cebp	B-GP
mRNA	O
and	O
protein	O
levels	O
in	O
a	O
clock	B-GP
-	O
dependent	O
manner	O
.	O
a	O
Liver	O
samples	O
were	O
collected	O
at	O
the	O
indicated	O
Circadian	O
Times	O
(	O
CT	O
)	O
from	O
regular	O
chow	O
-	O
fed	O
WT	O
and	O
Clock	B-GP
Δ19	O
/	O
Δ19	O
mutant	O
(	O
Clk	O
)	O
mice	B-OG
(	O
n	O
=	O
3	O
)	O
in	O
constant	O
darkness	O
(	O
DD	O
)	O
when	O
the	O
circadian	O
clock	B-GP
free	O
runs	O
devoid	O
of	O
light	O
cue	O
.	O

CT0	O
corresponds	O
to	O
the	O
onset	O
of	O
subjective	O
day	O
.	O

Western	O
blotting	O
was	O
performed	O
using	O
total	O
protein	O
extracts	O
from	O
the	O
liver	O
samples	O
with	O
the	O
indicated	O
antibodies	B-GP
.	O

See	O
Additional	O
file	O
1	O
:	O
Figure	O
S3	O
for	O
quantitative	O
analysis	O
.	O
b	O
Real	O
-	O
time	O
RT	O
-	O
PCR	O
analysis	O
of	O
Cps1	B-GP
,	O
Cebpa	B-GP
and	O
Cebpb	B-GP
was	O
carried	O
out	O
using	O
total	O
RNAs	O
extracted	O
from	O
the	O
liver	O
samples	O
described	O
in	O
(	O
a	O
).	O
Data	O
are	O
presented	O
as	O
mean	O
±	O
SEM	O
.	O

Two	O
-	O
way	O
ANOVA	O
with	O
Bonferroni	O
post	O
-	O
hoc	O
tests	O
,	O
WT	O
vs	O
.	O
Clk	O
,	O
Cps1	B-GP
,	O
Cebpb	B-GP
p	O
<	O
0	O
.	O
01	O
;	O
Cebpa	B-GP
p	O
<	O
0	O
.	O
05	O
.	O

Student	O
’	O
s	O
t	O
-	O
test	O
,	O
WT	O
vs	O
.	O
Clk	O
,	O
Cps1	B-GP
:	O
CT4	O
,	O
*	O
p	O
<	O
0	O
.	O
05	O
;	O
Cebpa	B-GP
:	O
CT8	O
,	O
*	O
p	O
<	O
0	O
.	O
05	O
;	O
Cebpb	B-GP
:	O
CT8	O
,	O
**	O
p	O
<	O
0	O
.	O
01	O
.	O
c	O
Western	O
blot	O
analysis	O
of	O
CPS1	B-GP
protein	O
levels	O
in	O
liver	O
samples	O
collected	O
at	O
ZT8	O
and	O
ZT20	O
from	O
WT	O
and	O
Clk	O
mice	B-OG
subjected	O
to	O
the	O
indicated	O
diet	O
and	O
treatment	O
.	O
RC	O
regular	O
chow	O
,	O
HFD	O
high	O
-	O
fat	O
diet	O
,	O
Veh	O
vehicle	O
,	O
NOB	O
Nobiletin	O
.	O

Two	O
-	O
way	O
ANOVA	O
with	O
Bonferroni	O
post	O
-	O
hoc	O
tests	O
,	O
WT	O
vs	O
.	O
individual	O
Clk	O
groups	O
,	O
*	O
p	O
<	O
0	O
.	O
05	O

NOB	O
modulated	O
serum	O
and	O
urine	O
urea	O
content	O

Finally	O
,	O
to	O
further	O
elucidate	O
a	O
modulatory	O
role	O
of	O
NOB	O
in	O
nitrogen	O
homeostasis	O
,	O
we	O
measured	O
urea	O
content	O
in	O
serum	O
and	O
urine	O
at	O
both	O
day	O
-	O
and	O
night	O
-	O
time	O
.	O

In	O
RC	O
,	O
serum	O
urea	O
levels	O
were	O
mildly	O
reduced	O
in	O
the	O
NOB	O
group	O
at	O
both	O
day	O
-	O
and	O
night	O
-	O
time	O
(	O
ZT6	O
and	O
18	O
)	O
(	O
Fig	O
.	O
7a	O
),	O
whereas	O
the	O
urine	O
urea	O
levels	O
showed	O
the	O
opposite	O
trend	O
,	O
suggesting	O
increased	O
urine	O
urea	O
excretion	O
by	O
NOB	O
(	O
Fig	O
.	O
7b	O
).	O

In	O
comparison	O
,	O
HFD	O
feeding	O
led	O
to	O
lower	O
serum	O
urea	O
levels	O
than	O
RC	O
(	O
Fig	O
.	O
7a	O
).	O

More	O
importantly	O
,	O
HFD	O
showed	O
a	O
reverse	O
NOB	O
response	O
;	O
specifically	O
,	O
NOB	O
increased	O
serum	O
urea	O
and	O
concomitantly	O
reduced	O
renal	O
urea	O
excretion	O
,	O
particularly	O
at	O
ZT18	O
(	O
Fig	O
.	O
7b	O
).	O

These	O
results	O
further	O
illustrated	O
a	O
modulatory	O
role	O
of	O
NOB	O
in	O
nitrogen	O
homeostasis	O
.	O
Fig	O
.	O
7Effects	O
of	O
NOB	O
on	O
urea	O
production	O
.	O
a	O
and	O
b	O
Serum	O
(	O
a	O
)	O
and	O
urine	O
(	O
b	O
)	O
urea	O
levels	O
at	O
ZT6	O
and	O
ZT18	O
in	O
WT	O
mice	B-OG
treated	O
with	O
Veh	O
or	O
NOB	O
under	O
RC	O
(	O
n	O
=	O
7	O
)	O
or	O
HFD	O
(	O
n	O
=	O
4	O
).	O

Data	O
are	O
presented	O
as	O
mean	O
±	O
SEM	O
.	O

Student	O
’	O
s	O
t	O
-	O
test	O
,	O
Veh	O
vs	O
.	O
NOB	O
,	O
*	O
p	O
<	O
0	O
.	O
05	O
;	O
RC	O
vs	O
.	O
HFD	O
,	O
†	O
p	O
<	O
0	O
.	O
05	O
,	O
††	O
p	O
<	O
0	O
.	O
01	O

Discussion	O

In	O
the	O
current	O
study	O
,	O
we	O
demonstrated	O
a	O
broad	O
effect	O
of	O
the	O
natural	O
flavonoid	O
NOB	O
in	O
reducing	O
serum	O
ammonia	O
levels	O
under	O
varying	O
diet	O
conditions	O
.	O

NOB	O
and	O
other	O
related	O
polymethoxylated	O
flavonoids	O
are	O
dietary	O
components	O
generally	O
showing	O
favorable	O
pharmacokinetic	O
profiles	O
[	O
61	O
,	O
62	O
],	O
and	O
mouse	B-OG
and	O
human	B-OG
studies	O
revealed	O
promising	O
efficacy	O
of	O
NOB	O
against	O
the	O
metabolic	B-DS
syndrome	I-DS
without	O
significant	O
toxicity	O
[	O
40	O
,	O
44	O
,	O
45	O
,	O
63	O
].	O

The	O
current	O
work	O
illustrated	O
a	O
novel	O
function	O
of	O
NOB	O
in	O
ammonia	O
disposal	O
,	O
extending	O
the	O
long	O
list	O
of	O
physiological	O
benefits	O
associated	O
with	O
NOB	O
and	O
other	O
natural	O
flavonoids	O
[	O
63	O
,	O
64	O
].	O

In	O
light	O
of	O
these	O
beneficial	O
attributes	O
,	O
it	O
warrants	O
further	O
investigation	O
whether	O
NOB	O
can	O
be	O
incorporated	O
into	O
dietary	O
management	O
for	O
congenital	O
and	O
injury	O
-	O
induced	O
hyperammonemia	B-DS
.	O

Our	O
study	O
revealed	O
broad	O
ammonia	O
-	O
lowering	O
activities	O
of	O
NOB	O
in	O
mice	B-OG
fed	O
with	O
RC	O
,	O
HFD	O
or	O
HPD	O
,	O
ostensibly	O
utilizing	O
distinct	O
,	O
diet	O
-	O
specific	O
mechanisms	O
.	O

Whereas	O
transcriptional	O
activation	O
of	O
CPS1	B-GP
via	O
C	B-GP
/	I-GP
EBP	I-GP
induction	O
seems	O
to	O
operate	O
under	O
HFD	O
,	O
NOB	O
treatment	O
in	O
conjunction	O
with	O
RC	O
and	O
HPD	O
feeding	O
appeared	O
not	O
to	O
elicit	O
significant	O
CPS1	B-GP
induction	O
.	O

Moreover	O
,	O
in	O
contrast	O
to	O
RC	O
where	O
NOB	O
similarly	O
reduced	O
serum	O
ammonia	O
at	O
both	O
ZT6	O
and	O
ZT18	O
,	O
in	O
HFD	O
and	O
HPD	O
NOB	O
more	O
strongly	O
diminished	O
the	O
relative	O
high	O
ammonia	O
levels	O
in	O
respective	O
diets	O
(	O
ZT6	O
for	O
HFD	O
and	O
ZT18	O
for	O
HPD	O
).	O

As	O
a	O
result	O
,	O
NOB	O
functions	O
to	O
reverse	O
the	O
exaggerated	O
ammonia	O
variation	O
between	O
the	O
active	O
and	O
inactive	O
phases	O
,	O
essentially	O
normalizing	O
circadian	O
ammonia	O
rhythm	O
in	O
HFD	O
and	O
HPD	O
to	O
RC	O
levels	O
.	O

Given	O
the	O
remarkably	O
diverse	O
cellular	O
pathways	O
known	O
to	O
be	O
modulated	O
by	O
NOB	O
and	O
other	O
flavonoids	O
,	O
various	O
molecular	O
and	O
cellular	O
mechanisms	O
may	O
underlie	O
such	O
mechanistic	O
and	O
functional	O
plasticity	O
[	O
63	O
–	O
67	O
].	O

Besides	O
transcriptional	O
regulation	O
(	O
C	B-GP
/	I-GP
EBP	I-GP
,	O
glucocorticoid	B-GP
receptor	I-GP
,	O
CREB	B-GP
and	O
HNF3	B-GP
)	O
and	O
the	O
allosteric	O
cofactor	O
NAG	O
[	O
7	O
,	O
17	O
],	O
recent	O
mechanistic	O
studies	O
have	O
also	O
underscored	O
the	O
importance	O
of	O
post	O
-	O
translational	O
modifications	O
(	O
PTMs	O
)	O
for	O
CPS1	B-GP
protein	O
activity	O
[	O
11	O
–	O
13	O
,	O
47	O
].	O

Other	O
urea	O
cycle	O
genes	O
may	O
also	O
serve	O
as	O
the	O
primary	O
target	O
;	O
one	O
such	O
candidate	O
is	O
Otc	B-GP
,	O
especially	O
given	O
its	O
functional	O
connection	O
with	O
the	O
circadian	O
clock	B-GP
[	O
19	O
].	O

Finally	O
,	O
NOB	O
may	O
also	O
attenuate	O
HPD	O
-	O
induced	O
bacterial	O
production	O
of	O
ammonia	O
by	O
amino	O
acid	O
deamination	O
and	O
urea	O
hydrolysis	O
[	O
4	O
].	O

Our	O
analysis	O
revealed	O
differential	O
responses	O
of	O
serum	O
and	O
urine	O
urea	O
levels	O
to	O
NOB	O
treatment	O
in	O
HFD	O
.	O

Urea	O
represents	O
the	O
most	O
predominant	O
circulating	O
nitrogen	O
reservoir	O
,	O
and	O
blood	O
urea	O
nitrogen	O
(	O
BUN	O
)	O
level	O
is	O
known	O
to	O
be	O
regulated	O
by	O
multiple	O
factors	O
including	O
protein	O
intake	O
,	O
protein	O
metabolism	O
and	O
renal	O
function	O
[	O
1	O
,	O
5	O
].	O

HFD	O
contains	O
lower	O
protein	O
content	O
than	O
RC	O
(	O
20	O
%	O
vs	O
.	O
29	O
%	O
in	O
calories	O
),	O
and	O
NOB	O
acts	O
to	O
attenuate	O
ammonia	O
levels	O
by	O
activating	O
urea	O
cycle	O
gene	O
expression	O
.	O

Thus	O
,	O
urea	O
may	O
be	O
salvaged	O
to	O
maintain	O
nitrogen	O
balance	O
in	O
the	O
HFD	O
.	O
NOB	O
condition	O
.	O

For	O
example	O
,	O
urine	O
excretion	O
rate	O
/	O
volume	O
and	O
renal	O
reabsorption	O
of	O
water	O
/	O
mineral	O
/	O
urea	O
are	O
tightly	O
coupled	O
to	O
regulate	O
osmotic	O
pressure	O
,	O
which	O
may	O
in	O
turn	O
modulate	O
serum	O
and	O
urine	O
urea	O
levels	O
.	O

However	O
,	O
a	O
direct	O
role	O
of	O
NOB	O
in	O
renal	O
function	O
remains	O
to	O
be	O
elucidated	O
.	O

Amino	O
acid	O
levels	O
in	O
human	B-OG
blood	O
have	O
been	O
shown	O
to	O
exhibit	O
robust	O
circadian	O
oscillation	O
,	O
concordant	O
with	O
results	O
from	O
a	O
yeast	B-OG
metabolic	O
cycle	O
resembling	O
mammalian	O
circadian	O
rhythm	O
[	O
68	O
–	O
70	O
].	O

In	O
parallel	O
with	O
fluctuating	O
amino	O
acid	O
levels	O
over	O
the	O
daily	O
cycle	O
,	O
CPS1	B-GP
and	O
several	O
other	O
urea	O
cycle	O
components	O
exhibited	O
circadian	O
mRNA	O
and	O
protein	O
expression	O
patterns	O
[	O
27	O
].	O

However	O
,	O
much	O
conflictory	O
evidence	O
has	O
also	O
been	O
reported	O
with	O
regard	O
to	O
Cps1	B-GP
circadian	O
expression	O
[	O
26	O
,	O
28	O
,	O
29	O
].	O

Our	O
experiments	O
,	O
using	O
specific	O
primers	O
and	O
antibodies	B-GP
,	O
revealed	O
weak	O
oscillation	O
of	O
Cps1	B-GP
mRNA	O
and	O
protein	O
.	O

Interestingly	O
,	O
NOB	O
appeared	O
to	O
augment	O
CPS1	B-GP
protein	O
oscillation	O
under	O
RC	O
,	O
and	O
also	O
enhanced	O
CPS1	B-GP
levels	O
under	O
HFD	O
in	O
a	O
circadian	O
clock	B-GP
-	O
dependent	O
manner	O
.	O

One	O
possible	O
mechanism	O
of	O
circadian	O
regulation	O
may	O
depend	O
on	O
C	B-GP
/	I-GP
EBPs	I-GP
as	O
their	O
expression	O
is	O
subjected	O
to	O
clock	B-GP
control	O
[	O
50	O
],	O
although	O
other	O
mechanisms	O
likely	O
exist	O
[	O
19	O
].	O

Of	O
note	O
,	O
we	O
observed	O
distinct	O
circadian	O
changes	O
of	O
C	B-GP
/	I-GP
EBPα	I-GP
p42	B-GP
and	O
p30	B-GP
isoforms	O
in	O
ClockΔ19	O
/	O
Δ19	O
mutant	O
mice	B-OG
relative	O
to	O
WT	O
,	O
suggesting	O
a	O
possible	O
circadian	O
regulation	O
of	O
alternative	O
translation	O
.	O

Currently	O
,	O
work	O
in	O
our	O
lab	O
aims	O
to	O
further	O
understand	O
the	O
detailed	O
mechanism	O
underlying	O
the	O
interaction	O
between	O
the	O
clock	B-GP
,	O
diet	O
and	O
NOB	O
in	O
nitrogen	O
homeostasis	O
.	O

Conclusion	O

In	O
this	O
current	O
study	O
,	O
we	O
present	O
physiological	O
evidence	O
indicating	O
that	O
NOB	O
exhibits	O
a	O
broad	O
activity	O
in	O
ammonia	O
control	O
in	O
mice	B-OG
fed	O
with	O
varying	O
diets	O
.	O

Molecular	O
experiments	O
further	O
revealed	O
that	O
NOB	O
regulates	O
urea	O
cycle	O
function	O
via	O
C	B-GP
/	I-GP
EBP	I-GP
-	O
and	O
circadian	O
clock	B-GP
-	O
dependent	O
regulatory	O
mechanisms	O
.	O

These	O
observations	O
together	O
demonstrate	O
a	O
novel	O
physiological	O
function	O
and	O
cellular	O
mechanism	O
of	O
a	O
natural	O
dietary	O
flavonoid	O
in	O
nitrogen	O
homeostasis	O
.	O

Primers	O
for	O
construction	O
of	O
reporter	O
constructs	O
.	O
Table	O
S2	O
.	O
Primers	O
for	O
real	O
-	O
time	O
qPCR	O
analysis	O
.	O
Table	O
S3	O
.	O
Mass	O
spectrometry	O
data	O
table	O
for	O
the	O
164KD	O
band	O
shown	O
in	O
the	O
Additional	O
file	O
1	O
:	O
Figure	O
S1B	O
.	O
Figure	O
S1	O
.	O
NOB	O
modulates	O
CPS1	B-GP
expression	O
.	O
(	O
A	O
)	O
Quantification	O
of	O
CPS1	B-GP
protein	O
levels	O
from	O
three	O
independent	O
experiments	O
including	O
the	O
blot	O
shown	O
in	O
Fig	O
.	O
2a	O
.	O

RC	O
,	O
regular	O
chow	O
;	O
HFD	O
,	O
high	O
-	O
fat	O
diet	O
;	O
Veh	O
,	O
vehicle	O
;	O
NOB	O
,	O
Nobiletin	O
.	O

Two	O
-	O
way	O
ANOVA	O
with	O
Bonferroni	O
post	O
-	O
hoc	O
tests	O
shows	O
significant	O
statistical	O
differences	O
between	O
HFD	O
.	O
Veh	O
and	O
other	O
three	O
groups	O
(	O
p	O
<	O
0	O
.	O
0001	O
).	O

Furthermore	O
,	O
one	O
-	O
way	O
ANOVA	O
with	O
Bonferroni	O
tests	O
shows	O
significant	O
difference	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
between	O
ZT	O
time	O
points	O
in	O
RC	O
.	O
Veh	O
but	O
not	O
in	O
other	O
groups	O
.	O
(	O
B	O
)	O
Coomassie	O
blue	O
staining	O
of	O
CPS1	B-GP
.	O

Mouse	B-OG
liver	O
protein	O
lysates	O
were	O
separated	O
on	O
SDS	O
-	O
PAGE	O
gel	O
and	O
stained	O
with	O
Coomassie	O
blue	O
.	O

The	O
predominant	O
164KD	O
band	O
was	O
validated	O
by	O
mass	O
spectrometry	O
as	O
CPS1	B-GP
(	O
Table	O
S3	O
).	O
(	O
C	O
)	O
Control	O
microscopy	O
images	O
for	O
Fig	O
.	O
2b	O
using	O
rabbit	B-OG
IgG	O
.	O
Figure	O
S2	O
.	O
NOB	O
rescued	O
C	B-GP
/	I-GP
EBP	I-GP
protein	O
circadian	O
expression	O
in	O
the	O
liver	O
from	O
HFD	O
fed	O
mice	B-OG
.	O
(	O
A	O
)	O
Quantification	O
of	O
C	B-GP
/	I-GP
EBPα	I-GP
p42	B-GP
protein	O
levels	O
from	O
three	O
independent	O
experiments	O
including	O
the	O
blot	O
shown	O
in	O
Fig	O
.	O
3b	O
.	O

Two	O
-	O
way	O
ANOVA	O
with	O
Bonferroni	O
post	O
-	O
hoc	O
tests	O
shows	O
significant	O
difference	O
between	O
RC	O
.	O
Veh	O
and	O
HFD	O
.	O
Veh	O
(	O
p	O
<	O
0	O
.	O
05	O
),	O
indicating	O
diet	O
effect	O
on	O
the	O
C	B-GP
/	I-GP
EBPα	I-GP
p42	B-GP
expression	O
level	O
.	O

Importantly	O
,	O
RC	O
.	O
NOB	O
was	O
not	O
significantly	O
different	O
from	O
HFD	O
.	O
NOB	O
,	O
suggesting	O
NOB	O
reversed	O
the	O
reducing	O
effect	O
of	O
HFD	O
on	O
the	O
C	B-GP
/	I-GP
EBPα	I-GP
p42	B-GP
expression	O
.	O
(	O
B	O
)	O
Quantification	O
of	O
C	B-GP
/	I-GP
EBPα	I-GP
p30	B-GP
protein	I-GP
levels	O
from	O
three	O
independent	O
experiments	O
including	O
the	O
blot	O
shown	O
in	O
Fig	O
.	O
3b	O
.	O

Two	O
-	O
way	O
ANOVA	O
with	O
Bonferroni	O
post	O
-	O
hoc	O
tests	O
shows	O
significant	O
difference	O
between	O
RC	O
.	O
Veh	O
and	O
HFD	O
.	O
Veh	O
(	O
p	O
<	O
0	O
.	O
01	O
),	O
but	O
RC	O
.	O
NOB	O
and	O
HFD	O
.	O
NOB	O
was	O
not	O
significantly	O
different	O
,	O
again	O
suggesting	O
NOB	O
reversed	O
the	O
reducing	O
effect	O
of	O
HFD	O
on	O
the	O
p30	B-GP
expression	O
.	O
(	O
C	O
)	O
Quantification	O
of	O
C	B-GP
/	I-GP
EBPβ	I-GP
protein	O
levels	O
from	O
three	O
independent	O
experiments	O
including	O
the	O
blot	O
shown	O
in	O
Fig	O
.	O
3b	O
.	O

Two	O
-	O
way	O
ANOVA	O
with	O
Bonferroni	O
post	O
-	O
hoc	O
tests	O
shows	O
significant	O
difference	O
between	O
RC	O
.	O
Veh	O
and	O
HFD	O
.	O
Veh	O
(	O
p	O
<	O
0	O
.	O
0001	O
),	O
but	O
RC	O
.	O
NOB	O
and	O
HFD	O
.	O
NOB	O
was	O
not	O
significantly	O
different	O
.	O
Figure	O
S3	O
.	O
NOB	O
restored	O
CPS1	B-GP
and	O
C	B-GP
/	I-GP
EBP	I-GP
protein	O
levels	O
in	O
a	O
clock	B-GP
-	O
dependent	O
manner	O
.	O
(	O
A	O
)	O
Quantification	O
of	O
CPS1	B-GP
protein	O
levels	O
under	O
constant	O
darkness	O
(	O
DD	O
)	O
conditions	O
from	O
three	O
independent	O
experiments	O
including	O
the	O
blot	O
shown	O
in	O
Fig	O
.	O
6a	O
.	O

Two	O
-	O
way	O
ANOVA	O
with	O
Bonferroni	O
post	O
-	O
hoc	O
tests	O
shows	O
significant	O
statistical	O
difference	O
between	O
WT	O
and	O
Clk	O
(	O
Clock	B-GP
Δ19	O
/	O
Δ19	O
)	O
(	O
p	O
<	O
0	O
.	O
0001	O
).	O
(	O
B	O
)	O
Quantification	O
of	O
C	B-GP
/	I-GP
EBPα	I-GP
p42	B-GP
protein	O
levels	O
under	O
constant	O
darkness	O
(	O
DD	O
)	O
conditions	O
from	O
three	O
independent	O
experiments	O
including	O
the	O
blot	O
shown	O
in	O
Fig	O
.	O
6a	O
.	O

Two	O
-	O
way	O
ANOVA	O
with	O
Bonferroni	O
post	O
-	O
hoc	O
tests	O
shows	O
significant	O
statistical	O
differences	O
between	O
WT	O
and	O
Clk	O
(	O
p	O
<	O
0	O
.	O
05	O
).	O
(	O
C	O
)	O
Quantification	O
of	O
C	B-GP
/	I-GP
EBPα	I-GP
p30	B-GP
protein	I-GP
levels	O
under	O
constant	O
darkness	O
(	O
DD	O
)	O
conditions	O
from	O
three	O
independent	O
experiments	O
including	O
the	O
blot	O
shown	O
in	O
Fig	O
.	O
6a	O
.	O

Two	O
-	O
way	O
ANOVA	O
with	O
Bonferroni	O
post	O
-	O
hoc	O
tests	O
shows	O
significant	O
statistical	O
difference	O
between	O
WT	O
and	O
Clk	O
(	O
p	O
<	O
0	O
.	O
01	O
).	O
(	O
D	O
)	O
Quantification	O
of	O
C	B-GP
/	I-GP
EBPβ	I-GP
protein	O
levels	O
under	O
constant	O
darkness	O
(	O
DD	O
)	O
conditions	O
from	O
three	O
independent	O
experiments	O
including	O
the	O
blot	O
shown	O
in	O
Fig	O
.	O
6a	O
.	O

Two	O
-	O
way	O
ANOVA	O
with	O
Bonferroni	O
post	O
-	O
hoc	O
tests	O
shows	O
significant	O
statistical	O
difference	O
between	O
WT	O
and	O
Clk	O
(	O
p	O
<	O
0	O
.	O
05	O
).	O

Kazunari	O
Nohara	O
and	O
Youngmin	O
Shin	O
contributed	O
equally	O
to	O
this	O
work	O
.	O

Competing	O
interests	O

The	O
authors	O
declare	O
no	O
competing	O
interests	O
.	O

Authors	O
’	O
contributions	O

KN	O
and	O
BH	O
carried	O
out	O
the	O
physiological	O
assays	O
.	O

YS	O
,	O
NP	O
and	O
KJ	O
carried	O
out	O
the	O
molecular	O
studies	O
.	O

NK	O
analyzed	O
promoter	O
sequences	O
and	O
gene	O
expression	O
.	O

KN	O
,	O
NP	O
and	O
SY	O
performed	O
the	O
statistical	O
analysis	O
.	O

SY	O
and	O
ZC	O
conceived	O
of	O
the	O
study	O
,	O
and	O
participated	O
in	O
its	O
design	O
and	O
coordination	O
and	O
drafted	O
the	O
manuscript	O
.	O

All	O
authors	O
read	O
and	O
approved	O
the	O
final	O
manuscript	O
.	O

